Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ravulizumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ravulizumab 1.1g/11ml solution for infusion vials
0901030T0AAAAAA
|
Ravulizumab | Ravulizumab | Nutrition and Blood | No data available |
|
Ravulizumab 300mg/30ml solution for infusion vials
0901030T0AAABAB
|
Ravulizumab | Ravulizumab | Nutrition and Blood | No data available |
|
Ravulizumab 300mg/3ml solution for infusion vials
0901030T0AAACAC
|
Ravulizumab | Ravulizumab | Nutrition and Blood | No data available |
|
Ultomiris 1,100mg/11ml concentrate for inf vials
0901030T0BBAAAA
|
Ultomiris | Ravulizumab | Nutrition and Blood | No data available |
|
Ultomiris 300mg/30ml concentrate for inf vials
0901030T0BBABAB
|
Ultomiris | Ravulizumab | Nutrition and Blood | No data available |
|
Ultomiris 300mg/3ml concentrate for inf vials
0901030T0BBACAC
|
Ultomiris | Ravulizumab | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.